๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A phase II trial of thalidomide in patients with refractory uterine carcinosarcoma and correlation with biomarkers of angiogenesis: A Gynecologic Oncology Group study

โœ Scribed by D. Scott McMeekin; Michael W. Sill; Kathleen M. Darcy; Ovadia Abulafia; Parviz Hanjani; Michael L. Pearl; Stephen C. Rubin; Peter G. Rose; Laurie Small; Doris Mangiaracina Benbrook

Book ID
118506794
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
543 KB
Volume
127
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A Phase III Trial of Ifosfamide with or
A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study
โœ Gregory Sutton; Virginia L. Brunetto; Larry Kilgore; John T. Soper; Ramon McGehe ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 61 KB

Objective. The aims of this study were to substantiate the previously reported activity of ifosfamide in patients with advanced, persistent, or recurrent carcinosarcoma (mixed mesodermal sarcoma) of the uterus, and to determine whether the addition of cisplatin results in an improved response or sur